Androgenic-anabolic steroid therapy and hepatocellular carcinoma.
D045930:Anabolic Agents / Q000009:adverse effects*; D000728:Androgens / Q000009:adverse effects*; D006528:Carcinoma, Hepatocellular / Q000139:chemically induced*; D002648:Child; D002675:Child, Preschool; D006511:Hepatitis B Antigens / Q000302:isolation & purification; D006801:Humans; D008099:Liver; D008113:Liver Neoplasms / Q000139:chemically induced*; D008297:Male; D008777:Methyltestosterone / Q000009:adverse effects; D009639:Norethandrolone / Q000009:adverse effects; D011877:Radionuclide Imaging; D013197:Stanozolol / Q000009:adverse effects
D045930:Anabolic Agents; D000728:Androgens; D006511:Hepatitis B Antigens; D013197:Stanozolol; D009639:Norethandrolone; D008777:Methyltestosterone